Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

Ayumi Fujimoto, Kana Miyazaki, Takeshi Maeda, Kimikazu Yakushijin, Wataru Munakata, Takahiro Fujino, Yasuo Ejima, Nobuhiro Hiramoto, Noriko Fukuhara, Jun Takizawa, Dai Maruyama, Nobuko Kubota, Hideki Goto, Rika Sakai, Senzo Taguchi, Naoko Asano, Fumihiro Ishida, Motoko Yamaguchi, Ritsuro Suzuki

Blood (2024) 144 (Supplement 1): 1682.

https://doi.org/10.1182/blood-2024-205065

Published: 2024

Journal Articles

The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin–transferrin receptor 1 axis

Blood (2023) 142 (4): 352–364.

https://doi.org/10.1182/blood.2022018597

Published: 2023

Includes: Supplemental data

Journal Articles

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

Blood (2023) 141 (9): 1036–1046.

https://doi.org/10.1182/blood.2021013489

Published: 2023

Includes: Supplemental data

Journal Articles

A Comprehensive, Multiomics Analysis of Natural Killer-Cell Malignancies

Petra Johanna Nygren, Aino Häkkinen, Daehong Kim, Timo Jarvinen, Fumihiro Ishida, Stefania Bortoluzzi, Andrea Binatti, Vanessa Rebecca Gasparini, Renato Zambello, Mikko Myllymäki, Seishi Ogawa, Yusuke Okuno, Hiroshi Kimura, John Chan, Olli Dufva, Satu Mustjoki, Matti Kankainen

Blood (2022) 140 (Supplement 1): 6390–6391.

https://doi.org/10.1182/blood-2022-162285

Published: 2022

Journal Articles

Improving Prognosis of Aggressive Natural Killer Cell Leukemia in Japan

Ayumi Fujimoto, Takeshi Maeda, Noriko Fukuhara, Kana Miyazaki, Motoko Yamaguchi, Fumihiro Ishida, Ritsuro Suzuki

Blood (2022) 140 (Supplement 1): 9435–9436.

https://doi.org/10.1182/blood-2022-165001

Published: 2022

Journal Articles

Synergistic Role of Leukemic and Non-Leukemic Immune Repertoires in CD8+ T-Cell Large Granular Lymphocytic Leukemia As Identified By Single-Cell Transcriptomics

Blood (2021) 138 (Supplement 1): 1318.

https://doi.org/10.1182/blood-2021-146539

Published: 2021

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

Ayumi Fujimoto, MD, Fumihiro Ishida, MD PhD, Koji Izutsu, MD PhD, Satoshi Yamasaki, MD PhD, Dai Chihara, MD PhD, Junji Suzumiya, MD PhD, Tetsuo Mitsui, MD PhD, Kazuteru Ohashi, MD PhD, Hideyuki Nakazawa, MD PhD, Hikaru Kobayashi, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2019) 134 (Supplement_1): 2032.

https://doi.org/10.1182/blood-2019-122049

Published: 2019

Journal Articles

STAT3 Mutations and Anemia with Pure Red Cell Aplasia Are the Distinctive Features of T Cell Receptor Gamma Delta Type Large Granular Lymphocyte Leukemia

Taku Yamane, Toru Kawakami, MD, Nodoka Sekiguchi, MD PhD, Jun Kobayashi, Toshimitsu Ueki, MD, Hikaru Kobayashi, MD PhD, Sayaka Nishina, Kaoko Sakai, MD, Hitoshi Sakai, MD, Kazuo Oshimi, MD, Yumiko Higuchi, PhD, Hideyuki Nakazawa, MD PhD, Fumihiro Ishida, MD PhD

Blood (2019) 134 (Supplement_1): 1500.

https://doi.org/10.1182/blood-2019-123614

Published: 2019

Journal Articles

Frequent STAT3 Mutations in CD8 + T Cells from Patients with Pure Red Cell Aplasia

Toru Kawakami, MD, Nodoka Sekiguchi, MD PhD, Jun Kobayashi, Tatsuya Imi, MD, Kazuyuki Matsuda, PhD, Taku Yamane, Sayaka Nishina, MD, Yasushi Senoo, MD, Hitoshi Sakai, MD PhD, Toshiro Ito, MD PhD, Tomonobu Koizumi, MD PhD, Makoto Hirokawa, MD PhD, Shinji Nakao, MD PhD, Hideyuki Nakazawa, PhD MD, Fumihiro Ishida, MD FACP

Blood (2018) 132 (Supplement 1): 536.

https://doi.org/10.1182/blood-2018-99-112132

Published: 2018

Journal Articles

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Makoto Hirokawa, MD PhD, Junki Kohmaru, Souichi Koyota, PhD, Keiji Kuba, MD, Naohito Fujishima, MD, Tomoo Saga, MD, Ayumi Omokawa, MD, Shigeharu Ueki, MD, Fumihiro Ishida, MD FACP, Shinji Nakao, MD PhD, Akira Matsuda, MD, Akiko Ohta, MD, Kaoru Tohyama, MD, Ryuji Suzuki, DVM, PhD, Kinuko Mitani, MD

Blood (2018) 132 (Supplement 1): 3858.

https://doi.org/10.1182/blood-2018-99-113262

Published: 2018

Journal Articles

Recurrent STAT3 Mutations in the Lymphocytes of Pure Red Cell Aplasia without T-Cell Large Granular Lymphocytic Leukemia

Toru Kawakami, MD, Nodoka Sekiguchi, MD, Toshiya Otsuka, Tatsuya Imi, MD, Sayaka Nishina, MD, Noriko Senoo, MD, Yasushi Senoo, MD, Hitoshi Sakai, MD, Toshiro Ito, MD PhD, Tomonobu Koizumi, MD PhD, Shinji Nakao, MD PhD, Hideyuki Nakazawa, MD PhD, Fumihiro Ishida, MD PhD

Blood (2017) 130 (Supplement 1): 1181.

https://doi.org/10.1182/blood.V130.Suppl_1.1181.1181

Published: 2017

Journal Articles

Mutational Landscape of Aggressive Natural Killer Cell Leukemia and Drug Sensitivity Profiling Reveal Therapeutic Options in Natural Killer Cell Malignancies

Blood (2016) 128 (22): 2921.

https://doi.org/10.1182/blood.V128.22.2921.2921

Published: 2016

Journal Articles

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia

Blood (2016) 128 (20): 2465–2468.

https://doi.org/10.1182/blood-2016-06-724856

Published: 2016

Includes: Supplemental data

Journal Articles

Screening Method for Hepatic Fibrinogen Storage Disease Associated with Congenital Hypofibrinogenemia

Shinpei Arai, MS, Saki Mukai, BA, Yuka Takezawa, PhD, Mitsutoshi Sugano, PhD, Takayuki Honda, MD PhD, Fumihiro Ishida, MD PhD, Nobuo Okumura, PhD

Blood (2015) 126 (23): 3504.

https://doi.org/10.1182/blood.V126.23.3504.3504

Published: 2015

Journal Articles

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

Blood (2015) 126 (23): 700.

https://doi.org/10.1182/blood.V126.23.700.700

Published: 2015

Journal Articles

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

Takahiro Tanahashi, Kazuyuki Matsuda, PhD, Nodoka Sekiguchi, MD PhD, Sayaka Nishina, MD, Noriko Senoo, MD, Kaoko Sakai, Hitoshi Sakai, MD, Toshiro Ito, MD PhD, Takeki Mitsui, MD, PhD, Yok Lam Kwong, MD, Fumihiro Ishida, MD PhD

Blood (2014) 124 (21): 1652.

https://doi.org/10.1182/blood.V124.21.1652.1652

Published: 2014

Journal Articles

Novel Prognostic Model Of Primary Mediastinal Large B-Cell Lymphoma (PMBL): A Multicenter Cooperative Retrospective Study In Japan

Tomohiro Aoki, M.D., Koji Izutsu, MD, PhD, Ritsuro Suzuki, MD, Chiaki Nakaseko, M.D., Ph.D., Hiroshi Arima, M.D., Kazuyuki Shimada, M.D., Ph.D., Makoto Sasaki, M.D., Ph.D., Jun Takizawa, M.D., Ph.D., Kinuko Mitani, M.D., Ph.D., Tadahiko Igarashi, M.D., Yoshinobu Maeda, M.D., Ph.D., Fumihiro Ishida, M.D., Nozomi Niitsu, M.D., Ph.D., Ken Ohmachi, M.D., Hirotaka Takasaki, M.D., Naoya Nakamura, M.D., Ph.D., Tomohiro Kinoshita, MD, PhD, Shigeo Nakamura, MD, PhD, Michinori Ogura, M.D., Ph.D.

Blood (2013) 122 (21): 638.

https://doi.org/10.1182/blood.V122.21.638.638

Published: 2013

Journal Articles

Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol.

Noriyoshi Iriyama, Yoshihiro Hatta, MD, PhD, Jin Takeuchi, MD, PhD, Yoshiaki Ogawa, MD, PhD, Shigeki Ohtake, MD, PhD, Toru Sakura, MD, PhD, Kinuko Mitani, MD, Fumihiro Ishida, MD, Masatomo Takahashi, MD, Tomoya Maeda, MD, PhD, Tohru Izumi, MD, Hisashi Sakamaki, MD, Shuichi Miyawaki, MD, Sumihisa Honda, PhD, Yasushi Miyazaki, MD, PhD, Tomohiko Taki, MD, PhD, Masafumi Taniwaki, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2012) 120 (21): 2511.

https://doi.org/10.1182/blood.V120.21.2511.2511

Published: 2012

Journal Articles

STAT3 Gene Mutations and the Association with Pure Red Cell Aplasia in Large Granular Lymphocyte Leukemia.

Nodoka Sekiguchi, MD, Kazuyuki Matsuda, PhD, Kayoko Momose, MD, Hideki Makishima, MD, PhD, Toshiro Ito, MD, Fumihiro Ishida, MD

Blood (2012) 120 (21): 2668.

https://doi.org/10.1182/blood.V120.21.2668.2668

Published: 2012

Journal Articles

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Nodoka Sekiguchi, MD, Naoko Asano, MD, Hideki Makishima, MD, PhD, Masanobu Momose, MT, Toshiro Ito, MD, Shigeo Nakamura, MD, Fumihiro Ishida, MD

Blood (2010) 116 (21): 4140.

https://doi.org/10.1182/blood.V116.21.4140.4140

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin–transferrin receptor 1 axis

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

A Comprehensive, Multiomics Analysis of Natural Killer-Cell Malignancies

Improving Prognosis of Aggressive Natural Killer Cell Leukemia in Japan

Synergistic Role of Leukemic and Non-Leukemic Immune Repertoires in CD8+ T-Cell Large Granular Lymphocytic Leukemia As Identified By Single-Cell Transcriptomics

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

STAT3 Mutations and Anemia with Pure Red Cell Aplasia Are the Distinctive Features of T Cell Receptor Gamma Delta Type Large Granular Lymphocyte Leukemia

Frequent STAT3 Mutations in CD8 + T Cells from Patients with Pure Red Cell Aplasia

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Recurrent STAT3 Mutations in the Lymphocytes of Pure Red Cell Aplasia without T-Cell Large Granular Lymphocytic Leukemia

Mutational Landscape of Aggressive Natural Killer Cell Leukemia and Drug Sensitivity Profiling Reveal Therapeutic Options in Natural Killer Cell Malignancies

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia

Screening Method for Hepatic Fibrinogen Storage Disease Associated with Congenital Hypofibrinogenemia

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

Novel Prognostic Model Of Primary Mediastinal Large B-Cell Lymphoma (PMBL): A Multicenter Cooperative Retrospective Study In Japan

Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol.

STAT3 Gene Mutations and the Association with Pure Red Cell Aplasia in Large Granular Lymphocyte Leukemia.

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only